On Friday, Evolent Health, Inc. (NYSE: EVH) stock observed trading -64.47% off 52-week high price. On the other end, the stock has been noted 40.36% away from low price over the last 52-weeks. The stock disclosed a move of -5.38% away from 50 day moving average and -18.75% away from 200 day moving average. Moving closer, we can see that shares have been trading -10.80% off 20-day moving average.
Evolent Health, Inc. (EVH) recently reported financial results for the quarter ended September 30, 2019.
We are not providing forward looking guidance for GAAP stated financial measures. A reconciliation of forward looking non-GAAP financial measures to the most comparable GAAP financial measure is provided in the “Guidance Reconciliation” table below.
For the full year 2019, we are narrowing the range for Adjusted Revenue to be in the range of $838.0M to $850.0M. The components of Adjusted Revenue include Adjusted Services Revenue, which is forecasted to be about $679.0M to $689.0M, and True Health premiums revenue, which is forecasted to be about $172.9M to $174.9M; intersection eliminations are forecasted to be about $(13.7)M for the full year. We are forecasting Adjusted EBITDA to be in the range of $(11.1)M to $(8.1)M.
For the three months ending December 31, 2019, Adjusted Revenue is predictable to be in the range of about $227.5M to $239.5M. The components of Adjusted Revenue include Adjusted Services Revenue, which is forecasted to be about $195.0M to $205.0M, and True Health premiums revenue, which is forecasted to be about $36.0M to $38.0M; intersection eliminations are forecasted to be about $(3.5)M for the quarter. Adjusted EBITDA is predictable to be in the range of about $8.0M to $11.0M.
This “Business Outlook” section contains forward-looking statements, and actual results may differ materially. Factors that may cause actual results to differ materially from our current expectations are set forth below in “Forward Looking Statements – Cautionary Language” and Evolent Health, Inc.’s filings with the Securities and Exchange Commission (“SEC”).
The USA based company Evolent Health, Inc. moved with change of -8.20% to $7.72 with the total traded volume of 1537658 shares in recent session versus to an average volume of 1613.13K. EVH’s shares are at 4.04% for the quarter and driving a -61.03% return over the course of the past year and is now at -61.30% since this point in 2018. Right now, the stock beta is 1.05. The average volatility for the week and month was at 12.36% and 11.38% respectively. There are 83.82M shares outstanding and 80.08M shares are floated in market.